Corpus Christi Medical Center (CCMC) Bay Area has earned an “A” and Doctors Regional a “B” for the spring 2022 Leapfrog Hospital Safety Grade, a national distinction recognizing achievements in protecting patients from preventable harm and error in the hospital.

“At Corpus Christi Medical Center, we exist to give patients a healthier tomorrow and patient safety is our top priority,” said Eric Evans, CEO of Corpus Christi Medical Center. “It is an honor for our hospitals to receive this recognition and a tremendous achievement to earn our 8th consecutive ‘A’ Hospital Safety Grade from The Leapfrog Group. This distinction is a reflection of our commitment to providing safe, top-quality medical care to our community.” 

The Leapfrog Group, an independent national watchdog organization, assigns an “A,” “B,” “C,” “D,” or “F” grade to general hospitals across the country based on over thirty national performance measures reflecting errors, accidents, injuries and infections, as well as systems hospitals have in place to prevent harm.

 The Leapfrog Hospital Safety Grade is the only hospital ratings program based exclusively on hospital prevention of medical errors and harm to patients. The grading system is peer-reviewed, fully transparent and free to the public. Grades are updated twice annually, in the fall and spring.

“As healthcare continues to evolve from the strain of the pandemic, I thank the workforce and leadership of Corpus Christi Medical Center for their sustained commitment to patient safety, day in and day out,” said Leah Binder, president and CEO of The Leapfrog Group. “An ‘A’ Safety Grade is an outstanding achievement, and one that is not possible without a 24/7 effort by the entire health care workforce to protect patients from harm. This community should be proud.”

CCMC has a long history of providing safe, quality care and has consistently earned top safety grades. To see the hospitals’ full grade details and to access patient tips for staying safe in the hospital, visit and follow The Leapfrog Group on Twitter and Facebook, and via its newsletter.